How should stakeholders understand sustainability?
When Jonathan and I got talking, we landed on a simple answer: it’s about using commercial common sense to build a more resilient business.
Watch now: https://t.co/0VWYR6nUE6
Asia-Pacific. The Middle East. Africa.
For Pascale Meulemeester, growth can’t rest on one single country.
Watch the full episode now: https://t.co/ZXmLNleBfw
“It drives resilience.”
This week, I’m joined by BAT’s Jonathan Upward and Deloitte’s Emily Cromwell, who made a powerful case for putting sustainability at the heart of business strategy.
Watch the trailer now!
What is a brand really for?
That's a question I posed to Daniel Bonner in the most recent episode.
His answer was simpler than I expected: “People like to believe in something.” In a world that is commoditised, a brand has to "stand out."
Watch now: https://t.co/oydbBUKGjt
Not everyone is built to be the visionary.
@WillGreenwood knows exactly where he fits: “I’m a really good number two.”
Watch the full episode now: https://t.co/sUr8oRV0O9
More channels. More noise. More complexity.
Daniel Bonner, Global Chief Creative Officer at WPP, on why a brand can’t be a “patchwork quilt” in today's fragmented media landscape. Consistency matters more than ever.
Watch now: https://t.co/oydbBULe91
“I've always been optimistic about the power of creativity.”
When I sat down with Daniel Bonner, one of the creative minds behind Omni™, we discussed bringing that mindset to BAT’s transformation and turning creative ambition into reality.
Watch now: https://t.co/oydbBULe91
Corporate tax and VAT get an industry consultation.
Excise doesn’t.
EU tax veteran Donato Raponi thinks ideology is to blame.
Full episode here: https://t.co/vcVP1JkGsP
“90% of your life you’re hearing no rather than yes.”
So how do you keep the ideas coming?
Daniel Bonner, one of the creative minds behind Omni™, shares what it takes to build a lasting career in the creative industry.
Watch the trailer now!
Does a chemistry PhD regret leaving academia?
Professor Douglas Deng put that question to my colleague, Dr James Murphy.
His answer? “A lot of jobs give reward…but few jobs give purpose.”
Find out why James joined BAT on The @SmokelessWord: Live from the Lab: https://t.co/abuyqsSOVK
Our industry has changed enormously since the WHO’s tobacco treaty was drafted 20 years ago.
So how should global policy respond?
Professor Douglas Deng shares his perspective on The @SmokelessWord: Live from the Lab.
Watch now: https://t.co/M0t0QjAvcn
One size doesn’t fit all.
Professor Douglas Deng breaks down why tobacco harm reduction policies must account for countries’ different economic structures, local industries and circumstances.
Watch The @SmokelessWord: Live from the Lab: https://t.co/M0t0QjAvcn
After 20 years in another industry, she left to join BAT.
Danni Tower explains what convinced her to make the move.
Watch the full episode: https://t.co/VKOunJi32z
Has tobacco harm reduction reached Asia?
It's a question my colleague, Dr James Murphy, puts to economist Professor Douglas Deng in the upcoming episode of The Smokeless Word: Live from the Lab.
His answer? Yes, but no two countries are the same.
Watch the trailer now!
What are we handing over to the next generation?
South Africa's former Statistician-General, Pali Lehohla (@palilj01), joins me to ask what today's decisions could mean for South Africa 50 or even 100 years from now - and why leaders must think beyond the immediate horizon.
Watch now: https://t.co/WmNaipbhid
Same goal. Different approaches. Different outcomes.
Download the New Omni™ 2026 Edition today: https://t.co/57ynu96lCn
Omni™ is intended for scientists, public health authorities, regulators, policymakers, and investors only, and is not intended for consumers.
The FT brings the Australian policy failure into sharp focus.
Illicit booming. Excise revenues collapsing. Hard won public health achievements reversed.
This is a catastrophic policy failure.
The solution is simple, pragmatic and would deliver a win:win:win.
Sadly, dogma prevails; common sense abandoned.
Read the full article here: https://t.co/jTp4eaB3TY
#Omni #SmokelessWorld #Transformation #ABetterTomorrow
Hazard: could this cause harm?
Risk: how likely is harm, under real conditions of exposure?
A distinction explored in the new Omni™ 2026 Edition, and critical to evidence-based regulation.
Omni™ is intended for scientists, public health authorities, regulators, policymakers, and investors only, and is not intended for consumers.
From our Group Head of Scientific Affairs, Danni Tower: https://t.co/EZWK04rlWR